Assessing Tumor-Infiltrating Lymphocytes in Breast Cancer: A Proposal for Combining Immunohistochemistry and Gene Expression Analysis to Refine Scoring.

Female Gene Expression Humans Immunohistochemistry Lymphocytes, Tumor-Infiltrating Reproducibility of Results Triple Negative Breast Neoplasms
breast cancer gene expression profiling immunohistochemistry immunotherapy targets tumor-infiltrating lymphocyte

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 13 10 2021
accepted: 06 01 2022
entrez: 28 2 2022
pubmed: 1 3 2022
medline: 9 4 2022
Statut: epublish

Résumé

Scoring of tumor-infiltrating lymphocytes (TILs) in breast cancer specimens has gained increasing attention, as TILs have prognostic and predictive value in HER2

Identifiants

DOI: 10.3389/fimmu.2022.794175 PMID: 35222378 PMC: PMC8876933
pubmed: 35222378
doi: 10.3389/fimmu.2022.794175
pmc: PMC8876933
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

794175

Informations de copyright

Copyright © 2022 Locy, Verhulst, Cools, Waelput, Brock, Cras, Schiettecatte, Jonckheere, van Grunsven, Vanhoeij, Thielemans and Breckpot.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancer Res. 2018 Sep 15;78(18):5200-5202
pubmed: 30217872
Ann Oncol. 2020 May;31(5):569-581
pubmed: 32278621
Front Immunol. 2020 Dec 02;11:553967
pubmed: 33343560
Neoplasma. 2016;63(5):789-98
pubmed: 27468884
Nat Rev Clin Oncol. 2016 Apr;13(4):228-41
pubmed: 26667975
J Clin Oncol. 2014 Sep 20;32(27):2959-66
pubmed: 25071121
Front Immunol. 2020 Aug 07;11:1779
pubmed: 32849640
Brief Bioinform. 2021 May 20;22(3):
pubmed: 32789507
Ann Oncol. 2014 Aug;25(8):1544-50
pubmed: 24608200
Mod Pathol. 2017 Sep;30(9):1204-1212
pubmed: 28621322
Cell. 2018 Aug 23;174(5):1293-1308.e36
pubmed: 29961579
J Clin Oncol. 2013 Mar 1;31(7):860-7
pubmed: 23341518
Breast Cancer Res Treat. 2018 Aug;171(1):1-9
pubmed: 29774470
Genome Biol. 2014;15(12):550
pubmed: 25516281
PLoS One. 2013 Dec 02;8(12):e79775
pubmed: 24312450
Front Immunol. 2018 Aug 31;9:1977
pubmed: 30233579
J Immunother Cancer. 2017 Feb 21;5:18
pubmed: 28239471
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28087938
J Transl Med. 2019 Jun 3;17(1):187
pubmed: 31159827
Adv Anat Pathol. 2017 Sep;24(5):235-251
pubmed: 28777142
Nat Med. 2008 May;14(5):518-27
pubmed: 18438415
Biomolecules. 2021 Apr 22;11(5):
pubmed: 33922016
Ann Oncol. 2015 Aug;26(8):1698-704
pubmed: 25995301
J Exp Clin Cancer Res. 2020 Aug 10;39(1):153
pubmed: 32778144
Ann Oncol. 2019 Oct 1;30(10):1541-1557
pubmed: 31373601
Immunol Cell Biol. 2017 Aug;95(7):611-619
pubmed: 28303902
NPJ Breast Cancer. 2020 May 12;6:17
pubmed: 32411819
Nat Commun. 2017 Jul 24;8:16041
pubmed: 28737175
J Clin Oncol. 2019 Mar 1;37(7):559-569
pubmed: 30650045
JCI Insight. 2020 May 7;5(9):
pubmed: 32376804
Mod Pathol. 2016 Oct;29(10):1155-64
pubmed: 27363491
J Oncol. 2019 Jun 27;2019:3980273
pubmed: 31346333
Cancer Res. 2020 Dec 1;80(23):5317-5329
pubmed: 33023944
Biochem Biophys Res Commun. 2014 Mar 14;445(3):645-50
pubmed: 24569077
Front Immunol. 2019 Aug 28;10:2037
pubmed: 31555270
Histopathology. 2020 Jul;77(1):79-91
pubmed: 32281132
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
World J Surg Oncol. 2021 Apr 13;19(1):113
pubmed: 33849563
Nat Commun. 2019 Dec 3;10(1):5499
pubmed: 31796750
Lancet Oncol. 2018 Jan;19(1):40-50
pubmed: 29233559
Oncol Lett. 2019 Mar;17(3):2647-2656
pubmed: 30867728
Front Oncol. 2020 Feb 25;10:188
pubmed: 32161718
Oncogene. 2019 Feb;38(6):767-779
pubmed: 30177835
J Obstet Gynaecol Res. 2019 Feb;45(2):428-437
pubmed: 30362198
Stem Cell Reports. 2020 Aug 11;15(2):307-316
pubmed: 32707076
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
J Clin Invest. 2021 Oct 1;131(19):
pubmed: 34411002
Breast Cancer Res Treat. 2020 Jan;179(1):37-45
pubmed: 31535319
J Clin Oncol. 2015 Mar 20;33(9):983-91
pubmed: 25534375
Biomedicines. 2018 Feb 11;6(1):
pubmed: 29439457
Nat Rev Cancer. 2020 Nov;20(11):662-680
pubmed: 32753728
Sci Rep. 2016 Jul 13;6:29521
pubmed: 27405665
Nat Biotechnol. 2014 Sep;32(9):896-902
pubmed: 25150836
Int J Mol Sci. 2020 Jun 22;21(12):
pubmed: 32580398
Acta Oncol. 2018 Jan;57(1):90-94
pubmed: 29168428
Front Immunol. 2019 May 24;10:1084
pubmed: 31178859
Pathobiology. 2020;87(2):125-142
pubmed: 32325459

Auteurs

Hanne Locy (H)

Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences (BMWE), Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Stefaan Verhulst (S)

Liver Cell Biology Research Group, BMWE, VUB, Brussels, Belgium.

Wilfried Cools (W)

Interfaculty Center Data processing and Statistics, VUB, Brussels, Belgium.

Wim Waelput (W)

Department of Anatomo-Pathology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Stefanie Brock (S)

Department of Anatomo-Pathology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Louise Cras (L)

Department of Anatomo-Pathology, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.

Ann Schiettecatte (A)

Department of Radiology, UZ Brussel, Brussels, Belgium.

Jan Jonckheere (J)

Department of Radiology, UZ Brussel, Brussels, Belgium.

Leo A van Grunsven (LA)

Liver Cell Biology Research Group, BMWE, VUB, Brussels, Belgium.

Marian Vanhoeij (M)

Department of Surgery, UZ Brussel, Brussels, Belgium.

Kris Thielemans (K)

Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences (BMWE), Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Karine Breckpot (K)

Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences (BMWE), Vrije Universiteit Brussel (VUB), Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Expression des gènes › Assessing Tumor-Infiltrating Lymphocytes in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Assessing Tumor-Infiltrating Lymphocytes in...
questionsmedicales.fr › Disciplines des sciences naturelles › Chimie › Biochimie › Immunohistochimie › Assessing Tumor-Infiltrating Lymphocytes in...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes TIL › Assessing Tumor-Infiltrating Lymphocytes in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Assessing Tumor-Infiltrating Lymphocytes in...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › Tumeurs du sein triple-négatives › Assessing Tumor-Infiltrating Lymphocytes in...